Content of the study:
The medical biology laboratory market - Italy

Available languages


1.1 Definition and presentation

Medical biology laboratories (LBMs), formerly known as medical analysis laboratories (MLAs), are places whose function is to perform medical diagnosis and monitoring based on samples of various human biological fluids. They are run by biologists.

The market for medical biology laboratories can be segmented according to the presence or absence of certification, inspection, testing and accreditation of the laboratories themselves.

Globally, the medical biology laboratory market is expected to grow to a value of about $303.1 billion by 2026, growing at a CAGR of 5.1 percent.

There are about 33,000 people working within this market in Italy.

The difference between accredited and non-accredited laboratories also falls in turnover. The turnover growth rate is much higher in accredited entities. In addition, accredited laboratories are considered much more efficient and with higher labor productivity.

it is important to consider the positive contribution that the medical biology laboratory industry makes to the development of the National Health Service. This industry has significant rates of investment in research and innovation, which are fundamental to the development of Italy's healthcare and economy.

The largest biomedical center can be found in Mirandola (Emilia Romagna). Northern Italy is in general the area where companies and turnover in this market are most concentrated. In Central Italy, most of the laboratories are concentrated in Lazio and Tuscany while as far as Southern Italy is concerned, we notice a smaller presence in general except for Campania, Puglia and Sicily.

This type of industry is extremely important at the healthcare level, and this was also demonstrated by the recent Covid-19 pandemic, which exposed all the flaws in the system and reiterated how necessary it is to invest in research and scientific innovation in order to increase the speed and accuracy of the medical tests that these laboratories perform.

1.2 The Global Market

The global clinical laboratory services market has been valued at $***.* billion in **** and is expected to expand at a compound annual growth rate(***) of *.* percent from **** to ****, to reach a value of ***.* billion.

Several dirvers will drive market growth, such as the increasing burden of chronic diseases and the growing demand ...

1.2 The Italian Market

In Italy in **** a total of **** outpatient/laboratory type health facilities were surveyed : the percentage of public facilities varies widely at the regional level; in general in the Central and Southern Regions there is a prevalence of accredited private facilities. An opposite situation is recorded with regard to other territorial facilities ...

1.4 Impact of Covid

Testing laboratories have been at the center of the global pandemic. it is clear that they have not been overly affected by the crisis, benefiting both from the continuity of business even during containment and from the increased demand for Covid-** testing.

There are several testing laboratories that, indeed, saw their ...


2.1 The main drivers of demand

Several drivers can drive the demand for private clinics in Italy. We can find two main categories, demographic characteristics of the Italian population and income characteristics .

The age distribution andmedian age of the Italian population are also important factors to consider in order to better understand this market and its ...

2.2 Geographic Distribution of Demand

In total, the number of laboratory tests in Italy in **** was ***.* million, a decrease of **.*% compared to ****. The number of tests performed has been decreasing over the years, marking -**.*% between **** and ****.

Number of clinical biological and chemical analyses, by year Italy, **** - ****, in millions of analyses Source: ****



* ...


3.1 Market Structure

In total, there are **** facilities in Italy surveyed under the Ateco Code"**.**.** Clinical Analysis Laboratories." The number of laboratories in Italy has been growing over the past * years, with +**.*% of laboratories between **** and ****. Interesting to note is the strong growth in the number of laboratories in ****, following the pandemic, with +*.*% of ...

3.2 The Staff of Medical Laboratories

Staffing of medical laboratories has been steadily increasing over the years. In ****, there were about **,*** staff, an increase of **.* percent over the past * years and fully in line with the increase in the number of enterprises in the sector. The average age of staff in the technical area is **.* years and ...

3.3 Geographic Distribution

As we have already seen, clinical analysis laboratories can have either a public form, and thus be funded and run by the state, or a private form. Regarding the laboratories under study in this analysis, there are **** public medical biology laboratories in Italy and **** in private form. The following map shows ...


4.1 Breakdown of medical biology expenses by pathology

Nearly **% of laboratory expenses are general expenses not related to a specific disease. These are routine care, analgesic treatments, occasional hospitalizations, etc. As for the rest of the expenditures, cardiovascular disease and cancer are the largest items with *.*% and *.*% of total expenditures, respectively.

These observations are logical, since the focus of ...

4.2 The different types of Laboratories

Two types of laboratories can be distinguished in the market:

Routine biology laboratories

Nonspecialized laboratories are the most prevalent in the area. Their role is to meet the classic demand for medical analysis. These laboratories are often clustered around technical platforms. A place that collects equipment shared by different health institutions, ...


5.1 Regulation

In Paragraph ***, Article * of Law No. ***/****, Finance Act ****, laboratory medicine activities are defined as follows : The activity of laboratory medicine provides information obtained by chemical, physical or biological methods on tissues or fluids of human origin or on materials related to human pathology, for the purpose of prevention, diagnosis, monitoring of ...


6.1 Segmentation

  • LUM Laboratorio Unico Metropolitano dell’Azienda Sanitaria
  • Life Brain Italia
  • CDC Gruppo Affidea
  • Synlab Italia SRL
  • Unilabs France
  • Gruppo San Donato
  • Eurofins

To keep reading, buy the full research

What is in this market study?

  • What are the figures on the size and growth of the market?
  • What is driving the growth of the market and its evolution?
  • What are the latest trends in this market?
  • What is the positioning of companies in the value chain?
  • How do companies in the market differ from each other?
  • Access company mapping and profiles.
  • Data from several dozen databases

  • This market study is available online and in pdf format (30 p.)
  • Consult an example PDF or online


Analysts 1 sector analyzed
in 40 pages


  • Top Universities
  • Expert opinion


  • Databases
  • Press
  • Company reports


  • Continuously updated
  • Permanent watch


  • Synthetic structure
  • Standardized charts

Reviews (3)

Reviews (3)

The Insulin Pump Market - France

Publicado en 11/01/2022 by Amaury Wernert

A very precise and detailed study of this market, driven by the strong growth of this disease in the world

Businesscoot Response:

Hello Amaury, Thank you for your feedback. We are happy to read that the content of the study has fully met your expectations. :)

The dental implant market - France

Publicado en 07/01/2022 by Denis Monnoyeur

The study highlights three trends: the dynamism of the market, the concentration of players and the practice of high prices.

Businesscoot Response:

Hello Denis, Thank you very much for this very positive review! We are delighted to see that you appreciate our studies and we thank you for the trust you have placed in us.

The Parapharmacy Market - France

Publicado en 07/01/2022 by Client anonyme - Ce client a souhaité rester anonyme

Clear and concise generic study. Well documented. However, I would have liked to see that the actors' files at the end of the report corresponded precisely to those stated in the report.

Businesscoot Response:

Hello, Thank you for your feedback on our study. We are planning to update it taking into account your remarks, we will keep you informed as soon as it is available.

Customer cases and references

Customer cases and references
La pépite Interview
Linkedin logo

BFM Business

La pépite Interview

Paul-Alexis Kebabtchieff
Linkedin logo

Boston Consulting Group

Paul-Alexis Kebabtchieff

Marie Guibart
Linkedin logo

Kea Partners

Marie Guibart

Elaine, Durand
Linkedin logo

Crédit Agricole, Information & Veille

Elaine, Durand

Philippe Dilasser
Linkedin logo

Initiative & Finance

Philippe Dilasser

Anne Baudry
Linkedin logo


Anne Baudry

Amaury Wernert
Linkedin logo

Kroll (Duff & Phelps)

Amaury Wernert

Smart Leaders Interview
Linkedin logo


Smart Leaders Interview